ZEKNUPA

Serial Number 97920305
606

Registration Progress

Application Filed
May 4, 2023
Under Examination
Sep 3, 2024
Approved for Publication
Jul 9, 2024
Published for Opposition
Jul 9, 2024
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: ZEKNUPA
Previous Owner: Crinetics Pharmaceuticals, Inc.
Classes: 005

Trademark Image

ZEKNUPA

Basic Information

Serial Number
97920305
Filing Date
May 4, 2023
Published for Opposition
July 9, 2024
Abandonment Date
October 6, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Oct 6, 2025
Classes
005

Rights Holder

Crinetics Pharmaceuticals, Inc.

03
Address
6055 Lusk Blvd.
San Diego, CA 92121

Ownership History

Crinetics Pharmaceuticals, Inc.

Original Applicant
03
San Diego, CA

Crinetics Pharmaceuticals, Inc.

Owner at Publication
03
San Diego, CA

Legal Representation

Attorney
Danny M. Awdeh

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

29 events
Date Code Type Description Documents
Oct 6, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Oct 6, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Mar 3, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 6, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 5, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 5, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 3, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 9, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 9, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 19, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 31, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 30, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 30, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 30, 2024 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Apr 5, 2024 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Apr 5, 2024 GNFR O FINAL REFUSAL E-MAILED Loading...
Apr 5, 2024 CNFR R FINAL REFUSAL WRITTEN Loading...
Mar 6, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 6, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 6, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 28, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 28, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Feb 28, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jan 30, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 30, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 30, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 30, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
May 9, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 8, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in treating endocrine disorders and endocrine-related diseases; pharmaceutical preparations for the treatment of acromegaly, carcinoid syndrome, neuroendocrine tumors, and cancer; all for human use

Classification

International Classes
005